ATE371018T1 - Le-zellen (liver engrafting cells), assays und verwendungen davon - Google Patents
Le-zellen (liver engrafting cells), assays und verwendungen davonInfo
- Publication number
- ATE371018T1 ATE371018T1 AT02742240T AT02742240T ATE371018T1 AT E371018 T1 ATE371018 T1 AT E371018T1 AT 02742240 T AT02742240 T AT 02742240T AT 02742240 T AT02742240 T AT 02742240T AT E371018 T1 ATE371018 T1 AT E371018T1
- Authority
- AT
- Austria
- Prior art keywords
- cells
- liver engrafting
- assay
- useful
- cell
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5067—Liver cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
- A01K67/027—New breeds of vertebrates
- A01K67/0271—Chimeric animals, e.g. comprising exogenous cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
- C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5073—Stem cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1394—Bone marrow stromal cells; whole marrow
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
- C12N2503/02—Drug screening
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30053501P | 2001-06-22 | 2001-06-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE371018T1 true ATE371018T1 (de) | 2007-09-15 |
Family
ID=23159503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02742240T ATE371018T1 (de) | 2001-06-22 | 2002-06-21 | Le-zellen (liver engrafting cells), assays und verwendungen davon |
Country Status (11)
Country | Link |
---|---|
US (3) | US7211404B2 (de) |
EP (3) | EP2388330B1 (de) |
JP (2) | JP4455876B2 (de) |
CN (2) | CN1665920A (de) |
AT (1) | ATE371018T1 (de) |
AU (1) | AU2002315392B2 (de) |
CA (1) | CA2451637C (de) |
DE (1) | DE60221987T2 (de) |
DK (1) | DK1406998T3 (de) |
ES (1) | ES2292772T3 (de) |
WO (1) | WO2003000848A2 (de) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8044259B2 (en) | 2000-08-03 | 2011-10-25 | The Regents Of The University Of Michigan | Determining the capability of a test compound to affect solid tumor stem cells |
US6984522B2 (en) * | 2000-08-03 | 2006-01-10 | Regents Of The University Of Michigan | Isolation and use of solid tumor stem cells |
US7838292B1 (en) * | 2001-03-29 | 2010-11-23 | University Of Louisville Research Foundation, Inc. | Methods for obtaining adult human olfactory progenitor cells |
EP2388330B1 (de) | 2001-06-22 | 2015-05-20 | StemCells, Inc. | Zellen zur Einpflanzung in die Leber, Assays dafür und Verwendungen davon |
US20040136972A1 (en) * | 2001-09-07 | 2004-07-15 | Yeda Research And Development Co. Ltd. | Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues |
US7780993B2 (en) * | 2001-09-07 | 2010-08-24 | Yeda Research And Development Co. Ltd. | Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts |
CA2469204A1 (en) * | 2001-12-07 | 2003-06-19 | Regents Of The University Of Michigan | Prospective identification and characterization of breast cancer stem cells |
IL165425A0 (en) * | 2004-11-28 | 2006-01-15 | Yeda Res & Dev | Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues |
EP2481814A3 (de) * | 2003-06-09 | 2012-10-10 | The Regents of the University of Michigan | Zusammensetzungen und Verfahren zur Behandlung und Diagnose von Krebs |
US20050014217A1 (en) * | 2003-07-18 | 2005-01-20 | Cytokinetics, Inc. | Predicting hepatotoxicity using cell based assays |
CA2554779A1 (en) * | 2004-02-03 | 2005-08-18 | The Regents Of The University Of Michigan | Compositions and methods for characterizing, regulating, diagnosing, and treating cancer |
KR101159573B1 (ko) * | 2004-08-20 | 2012-06-26 | 가부시키가이샤 페닉스바이오 | 약물의 사람에 있어서의 간대사 및 간기능의 예측방법 |
US20060252073A1 (en) * | 2005-04-18 | 2006-11-09 | Regents Of The University Of Michigan | Compositions and methods for the treatment of cancer |
JP2008546387A (ja) * | 2005-06-13 | 2008-12-25 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 癌を処置および診断するための組成物および方法 |
US20070099209A1 (en) * | 2005-06-13 | 2007-05-03 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
CA2628255C (en) * | 2005-10-31 | 2016-04-19 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
ES2618785T3 (es) | 2005-10-31 | 2017-06-22 | Oncomed Pharmaceuticals, Inc. | Composiciones y métodos para tratar el cáncer basados en receptores FZD humanos |
US7723477B2 (en) | 2005-10-31 | 2010-05-25 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth |
EP1969118B2 (de) | 2005-12-21 | 2014-09-10 | Université Catholique De Louvain | Isolierte leberstammzellen |
EP1998785A4 (de) * | 2006-02-21 | 2009-06-17 | Univ Michigan | Krebsbehandlung mithilfe eines hedgehog-signalisierungspfades |
EP2106439B1 (de) | 2007-01-24 | 2014-11-12 | The Regents of the University of Michigan | Zusammensetzungen und verfahren zur behandlung und diagnostizierung von pankreaskrebs |
KR101472519B1 (ko) * | 2007-06-05 | 2014-12-29 | 오레곤 헬스 앤드 사이언스 유니버시티 | In vivo에서 인간 간세포 증식 방법 |
CA2693481A1 (en) * | 2007-07-20 | 2009-01-29 | Cellartis Ab | A novel population of hepatocytes derived via definitive endoderm (de-hep) from human blastocysts derived stem cells |
US8241898B2 (en) * | 2007-12-10 | 2012-08-14 | The Board Of Trustees Of The Leland Stanford Junior University | Regenerative dot cells |
WO2009111778A2 (en) * | 2008-03-07 | 2009-09-11 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Lymph nodes as a site for regeneration |
CN105079805A (zh) | 2008-09-26 | 2015-11-25 | 昂考梅德药品有限公司 | 卷曲蛋白结合药剂及其应用 |
US20100227393A1 (en) * | 2009-03-06 | 2010-09-09 | Eric Lagasse | Liver stem cells: isolation of hepatic progenitor cells from the human gall bladder |
TWI535445B (zh) | 2010-01-12 | 2016-06-01 | 安可美德藥物股份有限公司 | Wnt拮抗劑及治療和篩選方法 |
JPWO2011102532A1 (ja) * | 2010-02-16 | 2013-06-17 | 国立大学法人九州大学 | 誘導肝細胞 |
CN102971337B (zh) | 2010-04-01 | 2016-09-21 | 昂考梅德药品有限公司 | 卷曲蛋白结合药剂及其应用 |
WO2014066328A1 (en) | 2012-10-23 | 2014-05-01 | Oncomed Pharmaceuticals, Inc. | Methods of treating neuroendocrine tumors using wnt pathway-binding agents |
CN105073195A (zh) | 2013-02-04 | 2015-11-18 | 昂科梅德制药有限公司 | 使用Wnt途径抑制剂进行治疗的方法及对该治疗的监测 |
US9168300B2 (en) | 2013-03-14 | 2015-10-27 | Oncomed Pharmaceuticals, Inc. | MET-binding agents and uses thereof |
JP6474394B2 (ja) | 2013-07-05 | 2019-02-27 | ユニベルシテ カトリック ドゥ ルーベン | ヒト成体肝臓幹細胞由来の馴化培地および肝臓障害の治療におけるその使用 |
JP6672603B2 (ja) * | 2015-03-27 | 2020-03-25 | 株式会社豊田中央研究所 | 物質と細胞との間の作用の評価方法 |
IL256342B2 (en) | 2015-06-23 | 2023-04-01 | Jackson Lab | A humanized nsg mouse model with hla-mismatched patient-derived grafts |
WO2018152488A1 (en) * | 2017-02-17 | 2018-08-23 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Fat-associated lymphoid clusters as sites for transplantation,tissue regeneration, organogenesis and function for multiple tissues |
WO2019210279A1 (en) * | 2018-04-27 | 2019-10-31 | The Regents Of The University Of California | De novo formation of the biliary system by hepatocyte transdifferentiation |
WO2023060186A1 (en) * | 2021-10-07 | 2023-04-13 | Hepatx Corporation | Methods of tracking donor cells in a recipient |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US6069005A (en) * | 1991-08-07 | 2000-05-30 | Albert Einstein College Of Medicine Of Yeshwa University | Hapatoblasts and method of isolating same |
EP1559778A1 (de) * | 1991-08-07 | 2005-08-03 | Albert Einstein College Of Medicine Of Yeshiva University | Proliferation von Hepatozytenvorläufern |
JP3789930B2 (ja) * | 1992-10-09 | 2006-06-28 | アドバンスド ティシュー サイエンシズ,インコーポレーテッド | 肝予備細胞 |
US5459037A (en) | 1993-11-12 | 1995-10-17 | The Scripps Research Institute | Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations |
CA2177043C (en) * | 1993-11-19 | 2011-08-09 | Lola C.M. Reid | Hepatoblasts and method of isolating same |
US5631734A (en) | 1994-02-10 | 1997-05-20 | Affymetrix, Inc. | Method and apparatus for detection of fluorescently labeled materials |
US5807522A (en) | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
WO1996039489A1 (en) | 1995-06-06 | 1996-12-12 | Whitehead Institute For Biomedical Research | Isolation of mammalian hematopoietic stem cells |
WO1996040875A1 (en) * | 1995-06-07 | 1996-12-19 | Novartis Ag | Methods for obtaining compositions enriched for hematopoietic stem cells and antibodies for use therein |
US5776683A (en) | 1996-07-11 | 1998-07-07 | California Pacific Medical Center | Methods for identifying genes amplified in cancer cells |
AU5195398A (en) * | 1996-10-25 | 1998-05-15 | Advanced Research And Technology Institute, Inc. | Dna sequences encoding fusions of dna repair proteins and uses thereof |
US6129911A (en) * | 1998-07-10 | 2000-10-10 | Rhode Island Hospital, A Lifespan Partner | Liver stem cell |
US6242666B1 (en) * | 1998-12-16 | 2001-06-05 | The Scripps Research Institute | Animal model for identifying a common stem/progenitor to liver cells and pancreatic cells |
US6468794B1 (en) | 1999-02-12 | 2002-10-22 | Stemcells, Inc. | Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
ES2351170T3 (es) | 1999-02-12 | 2011-02-01 | Stemcells California, Inc. | Poblaciones enriquecidas de células del sistema nervioso central. |
JP2004510432A (ja) | 2000-10-03 | 2004-04-08 | ユニバーシティ オブ ノース カロライナ | 両能性肝前駆細胞の単離方法 |
EP1559777A1 (de) * | 2001-04-24 | 2005-08-03 | Hokkaido Technology Licensing Office Co., Ltd. | Methode zur Reifung von Kolonien, die an kleinen Leberzellen reich sind, zu Lebergewebe |
EP2388330B1 (de) * | 2001-06-22 | 2015-05-20 | StemCells, Inc. | Zellen zur Einpflanzung in die Leber, Assays dafür und Verwendungen davon |
US8707400B2 (en) | 2007-01-22 | 2014-04-22 | Apple Inc. | System and method for implementing an extended authentication and authorization credential store |
-
2002
- 2002-06-21 EP EP20100178898 patent/EP2388330B1/de not_active Revoked
- 2002-06-21 AU AU2002315392A patent/AU2002315392B2/en not_active Expired
- 2002-06-21 CN CN028165284A patent/CN1665920A/zh active Pending
- 2002-06-21 WO PCT/US2002/019646 patent/WO2003000848A2/en active IP Right Grant
- 2002-06-21 DK DK02742240T patent/DK1406998T3/da active
- 2002-06-21 JP JP2003507235A patent/JP4455876B2/ja not_active Expired - Fee Related
- 2002-06-21 EP EP02742240A patent/EP1406998B1/de not_active Expired - Lifetime
- 2002-06-21 US US10/177,178 patent/US7211404B2/en not_active Expired - Lifetime
- 2002-06-21 DE DE60221987T patent/DE60221987T2/de not_active Expired - Lifetime
- 2002-06-21 ES ES02742240T patent/ES2292772T3/es not_active Expired - Lifetime
- 2002-06-21 EP EP07016341A patent/EP1956078A3/de not_active Withdrawn
- 2002-06-21 CA CA2451637A patent/CA2451637C/en not_active Expired - Lifetime
- 2002-06-21 AT AT02742240T patent/ATE371018T1/de not_active IP Right Cessation
- 2002-06-21 CN CN2010101654480A patent/CN101974480A/zh active Pending
-
2006
- 2006-08-09 US US11/502,210 patent/US7811818B2/en not_active Expired - Fee Related
-
2009
- 2009-04-03 JP JP2009090608A patent/JP2009183299A/ja not_active Withdrawn
-
2010
- 2010-08-10 US US12/853,477 patent/US8283164B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US7211404B2 (en) | 2007-05-01 |
DE60221987D1 (de) | 2007-10-04 |
EP1956078A2 (de) | 2008-08-13 |
CN101974480A (zh) | 2011-02-16 |
DE60221987T2 (de) | 2008-05-15 |
WO2003000848A2 (en) | 2003-01-03 |
EP1406998A2 (de) | 2004-04-14 |
US20070036774A1 (en) | 2007-02-15 |
US20110256625A1 (en) | 2011-10-20 |
AU2002315392B2 (en) | 2008-01-24 |
AU2002315392A2 (en) | 2003-01-08 |
EP2388330B1 (de) | 2015-05-20 |
EP2388330A1 (de) | 2011-11-23 |
CA2451637C (en) | 2013-04-23 |
US8283164B2 (en) | 2012-10-09 |
JP2009183299A (ja) | 2009-08-20 |
EP1406998A4 (de) | 2005-01-19 |
US7811818B2 (en) | 2010-10-12 |
WO2003000848A3 (en) | 2003-03-20 |
EP1956078A3 (de) | 2008-10-29 |
ES2292772T3 (es) | 2008-03-16 |
CA2451637A1 (en) | 2003-01-03 |
US20030032184A1 (en) | 2003-02-13 |
CN1665920A (zh) | 2005-09-07 |
JP4455876B2 (ja) | 2010-04-21 |
EP1406998B1 (de) | 2007-08-22 |
DK1406998T3 (da) | 2007-12-27 |
JP2004531270A (ja) | 2004-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE371018T1 (de) | Le-zellen (liver engrafting cells), assays und verwendungen davon | |
Ross et al. | TET enzymes, DNA demethylation and pluripotency | |
Morgani et al. | Totipotent embryonic stem cells arise in ground-state culture conditions | |
Kanatsu-Shinohara et al. | Serum-and feeder-free culture of mouse germline stem cells | |
Lian et al. | Derivation of clinically compliant MSCs from CD105+, CD24− differentiated human ESCs | |
Kim et al. | Changes in histone acetylation during mouse oocyte meiosis | |
Park et al. | Derivation of primordial germ cells from human embryonic and induced pluripotent stem cells is significantly improved by coculture with human fetal gonadal cells | |
Kim et al. | Histocompatible embryonic stem cells by parthenogenesis | |
Yu et al. | Human embryonic stem cells reprogram myeloid precursors following cell–cell fusion | |
Damelin et al. | Decatenation checkpoint deficiency in stem and progenitor cells | |
Wang et al. | Derivation and growing human embryonic stem cells on feeders derived from themselves | |
Risley | Connexin gene expression in seminiferous tubules of the Sprague-Dawley rat | |
Ohnuma et al. | Enzyme-free passage of human pluripotent stem cells by controlling divalent cations | |
CA2407505A1 (en) | Hepatocyte lineage cells derived from pluripotent stem cells | |
Umehara et al. | Efficient derivation of embryonic stem cells by inhibition of glycogen synthase kinase-3 | |
Welling et al. | Uncovering the true identity of naive pluripotent stem cells | |
ATE449837T1 (de) | Abstammungs-spezifische zellen und vorläuferzellen | |
Skårn et al. | Generation and characterization of an immortalized human mesenchymal stromal cell line | |
Torii et al. | Cementogenic potential of multipotential mesenchymal stem cells purified from the human periodontal ligament | |
Sahare et al. | Factors supporting long-term culture of bovine male germ cells | |
Mise et al. | Differences and similarities in the developmental status of embryo‐derived stem cells and primordial germ cells revealed by global expression profiling | |
Chen et al. | Stem cell maintenance by manipulating signaling pathways: past, current and future | |
Satoh et al. | Human DC3 antigen presenting dendritic cells from induced pluripotent stem cells | |
Di Giuseppe et al. | Cryopreservation effects on Wharton’s jelly stem cells proteome | |
Yaacobi-Artzi et al. | Association between the morphokinetics of in-vitro-derived bovine embryos and the transcriptomic profile of the derived blastocysts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |